STAG2 occupies enhancer and PRC2-marked regulatory regions, its loss leads to reprogramming of the oncogenic and neurodevelopmental transcriptomes and causes increased metastatic potential of Ewing sarcoma cells in mouse models [95–98]. The gene discussed is STAG2; the disease is Ewing sarcoma.